ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Prevention Program Being Developed For Primary Providers

January 29, 1988

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980

John Niederhuber Named Acting NCI Director.

June 2, 2006

Radio Host, Physician Elmer Huerta Becomes American Cancer Society President.

November 9, 2007